Logo.png
Cocrystal Pharma to Participate in the H.C. Wainwright Global Investment Conference
September 05, 2023 08:00 ET | Cocrystal Pharma, Inc.
BOTHELL, Wash., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing novel...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Antiviral Drugs Market Size Is Valued At USD 71.1 Bn by 2032 | CAGR of 3.73%
April 06, 2023 09:42 ET | Market.Us
New York, April 06, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the antiviral drugs market size is projected to surpass around USD 71.1 billion by 2032 from USD 49.8 billion in 2022, and it is...
visiongain Logo.png
Antiviral drugs market is projected to grow at a CAGR of 3.49% by 2032: Visiongain Reports Ltd
January 09, 2023 06:00 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled Antiviral Drugs 2022-2032. It includes profiles of Antiviral Drugs and Forecasts Market Segment by Drug Class (DNA Polymerase Inhibitors, Reverse...
visiongain Logo.png
Antiviral drugs market is projected to grow at a CAGR of 3.49% by 2032: Visiongain Reports Ltd
November 25, 2022 12:07 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled Antiviral Drugs 2022-2032. It includes profiles of Antiviral Drugs and Forecasts Market Segment by Drug Class (DNA Polymerase Inhibitors, Reverse...
Roots-Analysis-Logo.png
The antiviral drugs market is anticipated to grow at a CAGR of 6.3% during the period 2022-2035, claims Roots Analysis
November 01, 2022 15:00 ET | Roots Analysis
London, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Antiviral Drugs Market, 2022 – 2035” report to its list of offerings. The recent COVID-19 pandemic has...
Dr. William Haseltine releases new book on Innate Immunity and Covid-19
March 16, 2022 13:37 ET | ACCESS Health International
New York, March 16, 2022 (GLOBE NEWSWIRE) -- In his latest book, bestselling author William A. Haseltine Ph.D. tells us that understanding our natural immunity to the SARS-CoV-2 virus is critical...
visiongain Logo.png
Alzheimer’s Drugs Market Report to 2031: Visiongain Research Inc.
July 19, 2021 09:00 ET | Visiongain Ltd
Visiongain has published a new report on Alzheimer’s Drugs Market Report to 2031: Forecasts by Drugs (Donepezil, Rivastigmine, Galantamine, and Memantine), By Distribution Channel (Hospital...
visiongain-logo-72dpi.jpg
Global Antiviral Drugs Treatment Market is forecast to reach a market value of US$74.88 billion by 2031
May 27, 2021 05:09 ET | Visiongain Ltd
Visiongain has published a new report on Antiviral Drugs Treatment Market Report 2021-2031. Profiles of Antiviral Drugs Treatment and Forecasts By Drug Class (DNA Ploymerase Inhibitors, Reverse...
ARC logo.png
Antiviral Drugs Market Value Projected To Reach US$ 74.7 Billion By 2027: Acumen Research And Consulting
April 01, 2021 11:16 ET | Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Antiviral Drugs Market– Global Industry Analysis, Market Size, Opportunities and...
gmi logo.jpg
Antiviral Drugs Market revenue to cross USD 44.5 Bn by 2027: Global Market Insights Inc.
March 08, 2021 05:00 ET | Global Market Insights, Inc
Selbyville, Delaware, March 08, 2021 (GLOBE NEWSWIRE) -- According to latest report “Antiviral Drugs Market By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease...